Under New Management, Biosphere 2 Explores Research Opportunities

Blueprints for a Greenhouse Long plagued by logistical problems and dogged by controversy, the troubled Biosphere 2, under new management, is attempting to revitalize one of the most criticized aspects of the program--the quality of its science. Since the summer, more than a dozen geologists, biogeochemists, ecologists, and climate modelers have visited the 3.15-acre Oracle, Ariz., facility--the world's largest enclosed artificial

Written byNeeraja Sankaran
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Blueprints for a Greenhouse

Long plagued by logistical problems and dogged by controversy, the troubled Biosphere 2, under new management, is attempting to revitalize one of the most criticized aspects of the program--the quality of its science.

Since the summer, more than a dozen geologists, biogeochemists, ecologists, and climate modelers have visited the 3.15-acre Oracle, Ariz., facility--the world's largest enclosed artificial ecosystem--to evaluate its potential experimental uses and have made recommendations, in a series of "white papers," for various investigations that might take advantage of its unique features. The evaluation is part of an effort by the new management team to generate a long-term scientific plan and restructure the enterprise as a full-scale research center. The scientists' proposals span three broad areas of possible study within the facility: biogeochemical cycles; ecology and plant biology; and modeling systems.

A member of the new team of scientific consultants who is quite familiar ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies